Lumena
Closed- Business Model
- B2B
- Total Funding
- $8.0M
- Last Round
- $8.0M Series AJun 2025
- Rounds
- 1
About
Lumena Pharmaceuticals is developing oral therapeutics for rare liver diseases to improve liver function, relieve disease symptoms and dramatically impact patient health.
Summary
Lumena is a DeFi company. It has raised $8.0M in total across 1 round, most recently a $8.0M Series A round in Jun 2025.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Similar Companies
Payments & Loyalty Infrastructure
Mantle Network aims to be the "Liquidity Chain" to drive capital efficiency in the on-chain econo...
DEX aggregator enabling token swaps across 13+ blockchains at best rates.
Web3 infrastructure for debt capital markets connecting institutional investors with loan origina...
DeFi network on Polkadot providing aUSD stablecoin, cross-chain liquidity, staking, lending, and ...
Peer-to-peer onchain derivatives trading protocol